logo

For the Inventor, By the Inventor

Tokyo, Japan

Shinji Saijou

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: National Cancer Center, Rin Institute Inc.. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Saijou. Retrieved from https://idiyas.com/inventor/shinji-saijou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


Average Co-Inventor Count = 4.5

ph-index = 1


Location History:

  • Tokyo, JP (2019 - 2022)
  • Chiba, JP (2023)

Company Filing History:

goldMedal3 out of 263 
 
National Cancer Center
 patents
silverMedal3 out of 8 
 
Rin Institute Inc.
 patents
where one patent can have more than one assignee

Years Active: 2019-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents
1. 11633499 - Anti-TMEM-180 antibody, anticancer drug and cancer testing method (2023-04-25),
2. 11524074 - Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and cancer testing method (2022-12-13),
3. 10471146 - Cancer-cell-specific anti-transmembrane protein 180 antibody, anticancer drug, and cancer testing method (2019-11-12),

Title: Innovations of Shinji Saijou in Cancer Treatment

Introduction

Shinji Saijou is a prominent inventor based in Tokyo, Japan, known for his significant contributions to cancer research and treatment. With a total of 3 patents, he has focused on developing innovative solutions that target specific molecules in cancer cells.

Latest Patents

Saijou's latest patents include the development of an anti-TMEM-180 antibody, an anticancer drug, and a cancer testing method. The objective of these inventions is to provide an effective anticancer drug that can treat cancer by identifying a target molecule specifically expressed in cancer cells. This drug acts on the target molecule, enhancing the treatment's efficacy. Additionally, his cancer testing method involves measuring the amount of TMEM-180 in samples collected from subjects, facilitating early detection and treatment of cancer.

Career Highlights

Throughout his career, Shinji Saijou has worked with notable organizations such as Rin Institute Inc. and the National Cancer Center. His work in these institutions has allowed him to collaborate with leading experts in the field, further advancing his research and innovations.

Collaborations

Some of his notable coworkers include Yasuhiro Matsumura and Masahiro Yasunaga. Their collaboration has contributed to the development of groundbreaking cancer treatment methodologies.

Conclusion

Shinji Saijou's innovative work in cancer treatment through his patents demonstrates his commitment to improving healthcare outcomes. His contributions are paving the way for more effective cancer therapies and testing methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…